Form 990 for tax year 2023
Filed by AMYLOIDOSIS RESEARCH CONSORTIUM INC.
Totals
- Total revenue
- $2,888,025
- Total expenses
- $2,415,059
- Contributions and grants received
- $2,702,741
- Grants paid
- $0
- Program service revenue
- $1,525
- Investment income
- $54,751
- Other revenue
- $129,008
- Total assets, end of year
- $2,975,266
- Total liabilities, end of year
- $226,503
- Net assets or fund balances, end of year
- $2,748,763
- Program services expenses (Part IX)
- $1,548,608
- Management and general expenses
- $341,679
- Fundraising expenses
- $524,772
- Program service expenses (Part III)
- $1,548,608
Program services were 64.1% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$2,702,741
-
2a · Program service revenue: HONORARIUM AND CONSULT
total $1,525 · related or exempt $1,525
-
3 · Investment income
total $54,751 · excluded $54,751
-
5 · Royalties
total $46,942 · related or exempt $46,942
-
11a · Other revenue: OTHER MISCELLANEOUS IN
total $82,066 · related or exempt $82,066
-
11e · Other revenue, total
$82,066
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $178,365 · program services $118,909 · management and general $29,728 · fundraising $29,728
-
7 · Other salaries and wages
total $1,130,531 · program services $730,856 · management and general $31,435 · fundraising $368,240
-
9 · Other employee benefits
total $69,521 · program services $45,985 · management and general $1,755 · fundraising $21,781
-
10 · Payroll taxes
total $119,545 · program services $69,221 · management and general $16,073 · fundraising $34,251
-
11b · Fees: legal
total $135 · management and general $135
-
11c · Fees: accounting
total $105,936 · management and general $105,936
-
11g · Fees: other
total $409,911 · program services $366,469 · management and general $32,623 · fundraising $10,819
-
12 · Advertising and promotion
total $32,788 · program services $14,427 · management and general $2,452 · fundraising $15,909
-
13 · Office expenses
total $14,770 · program services $3,642 · management and general $7,655 · fundraising $3,473
-
16 · Occupancy
total $47,519 · management and general $47,519
-
17 · Travel
total $143,438 · program services $112,104 · management and general $8,992 · fundraising $22,342
-
19 · Conferences, conventions and meetings
total $14,852 · program services $14,339 · fundraising $513
-
22 · Depreciation, depletion and amortization
total $14,324 · management and general $14,324
-
23 · Insurance
total $6,334 · program services $1,044 · management and general $5,290
-
24a · Other expenses: PROGRAM MATERIALS
total $65,015 · program services $59,490 · fundraising $5,525
-
24b · Other expenses: WEBSITE AND INTERNET
total $53,132 · program services $8,802 · management and general $33,278 · fundraising $11,052
-
24c · Other expenses: DUES, FEES, AND LICESNE
total $6,078 · program services $2,029 · management and general $4,049
-
24d · Other expenses: TELEPHONE
total $2,257 · program services $1,291 · management and general $322 · fundraising $644
-
24e · All other expenses
total $608 · management and general $113 · fundraising $495
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $572,485 · end of year $269,622
-
2 · Savings and temporary cash investments
beginning of year $226,338 · end of year $565,116
-
3 · Pledges and grants receivable
beginning of year $38,138 · end of year $64,903
-
9 · Prepaid expenses and deferred charges
beginning of year $25,735 · end of year $24,958
-
10a · Land, buildings and equipment: cost or other basis
$20,721
-
10b · Land, buildings and equipment: accumulated depreciation
$11,797
-
10c · Land, buildings and equipment, net
beginning of year $11,026 · end of year $8,924
-
11 · Investments: publicly traded securities
beginning of year $1,633,842 · end of year $2,041,743
-
14 · Intangible assets
beginning of year $8,666
-
17 · Accounts payable and accrued expenses
beginning of year $300,880 · end of year $226,503
-
27 · Net assets without donor restrictions
beginning of year $1,504,656 · end of year $1,925,811
-
28 · Net assets with donor restrictions
beginning of year $710,694 · end of year $822,952
Mission and programs · 2023
Mission
ACCELERATING THE DEVELOPMENT OF ADVANCED DIAGNOSTIC TOOLS AND EFFECTIVE TREATMENTS FOR SYSTEMIC AMYLOIDOSIS THROUGH COLLABORATION AND INNOVATION.
-
RESEARCH PROGRAMS:ARC HAS BEEN WORKING ON A NUMBER OF RESEARCH INITIATIVES INCLUDING DATASHARING, AND PATIENT EXPERIENCE STUDIES. ARC HAS ALSO DEVELOPED AN APPOINTMENT COMPANION TOOL THAT SUPPORTS PATIENTS THROUGHOUT THEIR TREATMENT JOURNEY. THE ANONYMIZED AGGREGATED DATA PROVIDES VALUABLE REAL WORLD INCITES. ARC IS DEVELOPING A PATIENT REPORTED OUTCOMES TOOL FOR USE IN CLINICAL PRACTICE.
Expenses $313,283
-
AWARENESS, EDUCATIONAL PROGRAMS AND ADVOCACY:ARC'S PATIENT AND HEALTHCARE PROFESSIONAL PROGRAMS EDUCATE PHYSICIANS AND TAILOR INFORMATION TO SUIT THE PATIENT'S NEEDS AND ARE SUCCESSFULLY MATCHING THEM TO BETTER TREATMENT CENTERS, CARE, AND CLINICAL TRIALS. ARC'S PATIENT ADVISORY BOARD ARE INSTRUMENTAL IN DEFINING AND PRIORITIZING ARC'S PATIENT PROGRAMS. ARC'S PATIENT SUPPORT SPECIALIST PROVIDES INFORMATION AND GUIDANCE FOR PATIENTS THROUGHOUT THEIR JOURNEY. ARC ALSO MAINTAINS A COMPREHENSIVE WEBSITE WITH THE LATEST INFORMATION AND NEWS ABOUT AMYLOIDOSIS. ARC'S UNIQUE AMYLOIDOSIS PATHFINDER TOOL SUPPORTS PATIENTS IN FINDING AND EVALUATING TREATMENT CENTERS AND MATCHING THEM WITH CLINICAL TRIALS. THIS TOOL HAS BEEN FURTHER ENHANCED TO SUPPORT PATIENTS WITH TELEHEALTH VISITS AND VIRTUAL CARE DURING THE PANDEMIC. ARC ALSO HOSTS ARC TALKS, A REGULAR PATIENT EDUCATIONAL WEBINAR SERIES COVERING A RANGE OF IMPORTANT TOPICS. ARC HAS DEVELOPED BOOKLETS, AND HANDOUTS TO PROVIDE PATIENTS WITH IN DEPTH INFORMATION ON AMYLOIDOSIS RELATED TOPICS.
Expenses $524,965
-
HEALTHCARE PROFESSIONAL EDUCATION:ARC HAS CARRIED OUT RESEARCH TO UNDERSTAND THE BARRIERS AND PATHWAYS TO EARLY DIAGNOSIS. FROM THIS RESEARCH, ARC DEVELOPED AND IMPLEMENT TARGETED SOLUTIONS. ARC RAISES AWARENESS AND PROVIDES PHYSICIAN EDUCATION ON THE SIGNS, SYMPTOMS, AND CARE OF AMYLOIDOSIS TO RAISE THE LEVEL OF SUSPICION, IMPROVE THE SPEED OF DIAGNOSIS, AND STANDARDS OF CARE. ARC HELD A MASTERCLASS FOR PHYSICIANS AND NURSES IN DALLAS, TX FOCUSED ON ADDRESSING THE CHALLENGES OF ACCURATE DIAGNOSIS AND MANAGING CARE. ARC HAS PUBLISHED PEER REVIEWED CONSENSUS GUIDELINES DEFINING PATHWAY FOR SUSPICION AND DIAGNOSIS WITH A FOCUS ON CARDIOLOGY AND GENERAL PRACTICE. ARC SPONSORED A SATELLITE SYMPOSIUM AT THE HFSA CONFERENCE ON THE DIAGNOSIS AND TREATMENT OF CARDIAC AMYLOIDOSIS.
Expenses $357,241
-
Expenses $353,119 · Revenue $130,533
As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
ISABELLE LOUSADA
PRESIDENT/CEO & SECRETARY
- Total calculated
- $178,365
- From this org
- $178,365
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $178,365
- Bonus
- $0
- Other
- $0
- Deferred
- $0
- Nontaxable benefits
- $0
- Filer's total
- $178,365
-
SARAH CAIRNS-SMITH
CHAIR
- Total calculated
- $0
- Hours/week
- 0.25
-
RICK NATHANSON
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.25
-
DR RAYMOND COMENZO
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.25
-
JASON SHORE
TREASURER
- Total calculated
- $0
- Hours/week
- 0.25
-
DENA HEATH
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 3
-
DR ASHUTOSH WECHALEKAR
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.25
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2023
- Filed
- 29 October 2024
- IRS schema version
- 2023v5.1
- Source object
- 202423129349300612
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.